Rhône Vallée Angels
Valence, France1
6M
1
0.07
- Areas of investment
Investor highlights
- Stage focus
Discover reliable insights
Find relevant VC investors, identify key contacts and secure funding opportunities.
Investments analytics
Analytics
- Total investments
- 1
- Lead investments
- 0
- Rounds per year
- 0.07
- Investments by industry
- Medical Device (1)
- Health Care (1)
- Investments by region
- France (1)
- Peak activity year
- 2023
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 2
- Group Appearance index
- 1.00
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
| Company name | Deal date | Industry | Deal stage | Deal size | Location |
|---|---|---|---|---|---|
| MAG4HEALTH | 23 May 2023 | Health Care, Medical Device | Seed | 6M | Rhone-Alpes, Grenoble, France |
| Company name | Deal date | Industry | Deal stage | Deal size | Location |
|---|---|---|---|---|---|
| Octave Bioscience | Sep 5, 2025 | Biomarker-driven Solutions, Blood Test, Clinical Care Program, Disease Management, Healthcare Analytics, Healthcare Collaboration, Healthcare Technology, Measurement Tools, MRI Analytics, Neurodegenerative Disease Management, Neurodegenerative Diseases, Precision Care, Precision Medicine | - | 35600000 USD |  Menlo Park, California |
| Apaleo | Nov 21, 2024 | API-first open property management platform, API-first Property Management, Hospitality Management, Hotel and serviced apartment management | - | 20000000 EUR |  Munich, Bavaria |
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.